ALEXIS SHAFII to Matrix Metalloproteinase Inhibitors
This is a "connection" page, showing publications ALEXIS SHAFII has written about Matrix Metalloproteinase Inhibitors.
Connection Strength
0.055
-
Addition of matrix metalloproteinase inhibition to conventional cytotoxic therapy reduces tumor implantation and prolongs survival in a murine model of human pancreatic cancer. Cancer Res. 2000 Jun 15; 60(12):3207-11.
Score: 0.045
-
Matrix metalloproteinase (MMP) inhibition selectively decreases type II MMP activity in a murine model of pancreatic cancer. J Surg Res. 1999 Jan; 81(1):65-8.
Score: 0.010